Fingolimod hydrochloride
Price | USD1.00 |
Packge | 1KG |
- Min. Order:1G
- Supply Ability:100KG
- Time:2019-07-06
Product Details
- Product NameFingolimod hydrochloride
- CAS No.162359-56-0
- EINECS No.680-631-1
- MFC19H34ClNO2
- MW343.93
- Appearancepowderwhite to beige
- Melting point 102-107°C
- storage temp. -20°C
AD68
Fingolimod hydrochloride Basic information |
Product Name: | Fingolimod hydrochloride |
Synonyms: | Fingolimod (FTY720) hydrochloride;Fin;limod hydrochloride;fingolimod hydrochloride;FTY720;2-AMINO-2-[2-(4-OCTYLPHENYL)ETHYL]-1,3-PROPANEDIOL, HYDROCHLORIDE;2-amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol hydrochloride;Fingolimod HCl |
CAS: | 162359-56-0 |
MF: | C19H34ClNO2 |
MW: | 343.93 |
EINECS: | 1308068-626-2 |
Product Categories: | All Inhibitors;Inhibitors;Metabolites;Pharmaceutical intermediate;Pharmaceuticals;Aromatics;Intermediates & Fine Chemicals;Metabolites & Impurities;API;Other APIs |
Mol File: | 162359-56-0.mol |
Fingolimod hydrochloride Chemical Properties |
Melting point | 102-107°C |
storage temp. | -20°C Freezer |
solubility | water: soluble10mg/mL, clear |
color | white to beige |
Merck | 14,4083 |
CAS DataBase Reference | 162359-56-0(CAS DataBase Reference) |
Safety Information |
Hazard Codes | Xi |
Risk Statements | 36/37/38-52/53 |
Safety Statements | 26-61 |
RTECS | TY3130000 |
HS Code | 29221990 |
Toxicity | LD50 orally in rats: 300-600 mg/kg (Troncoso) |
Fingolimod hydrochloride Usage And Synthesis |
Oral drug for the treatment of multiple sclerosis | Fingolimod hydrochloride is the first oral drug for the treatment of multiple sclerosis. It is successfully developed by the pharmaceutical company Novartis, and it has been approved for marketing by the US Food and Drug Administration (FDA). The recommended dose is 0.5mg once a day for oral administration. Multiple sclerosis is a debilitating neurological disease that can cause the patient to lose a sense of balance, appear muscle spasms and other movement disorders. The disease has been treated with injectable drugs. This kind of medication brought great inconvenience to patients. Fingolimod is a sphingosine-l-phosphate (S1PR) receptor modulator. After phosphorylation, It is bound to s1P receptor that is on the surface of lymphocyte, which will change lymphocyte migration, and promote cells into the lymphatic tissue, and prevent lymphocytes from leaving the lymphoid tissue and get into the graft. Thereby, it will prevent these cells from infiltrating the central nervous system (CNS), which achieves the effect of immunosuppression. According to the drug's introduction, drugmaker Novartis said that this process of pharmacological effects is reversible. If medication is stopped, the level of lymphocytes in circulating system will return to normal. The above information is edited by the chemicalbook of Kui Ming. |
Chemical Properties | White Solid |
Uses | A derivative of ISP-1 (myriocin), a fungal metabolite of the Chinese herb Iscaria sinclarii as well as a structural analogue of Sphingosine. It is a novel immune modulator that prolongs allograft transplant survival in numberour models by inhibitin |
Uses | A derivative of ISP-1 (myriocin), a fungal metabolite of the Chinese herb Iscaria sinclarii as well as a structural analogue of Sphingosine. t is a novel immune modulator that prolongs allograft transplant survival in numberour models by inhibiting lymphocyte emigration from lymphoid organs. Reported to be phosphorylated by sphingosine kinase to FTY720-P, which has been shown to potently stimulate GTPgS binding activity in S1P-transfected CHO cells (EC50 = 210 pM, 4.9 nM, 4.3 nM, and 1 nM for S1P1, S1P3, S1P4 and S1P5, respectively). |
Uses | Oral medicine for the treatment of multiple sclerosis |
Uses | FTY720 is a derivative of ISP-1 (myriocin), a fungal metabolite of the Chinese herb Iscaria sinclarii as well as a structural analogue of Sphingosine. FTY720 is a novel immune modulator that prolong s allograft transplant survival in numberour models by inhibiting lymphocyte emigration from lymphoid organs. FTY720 us reported to be phosphorylated by sphingosine kinase to FTY720-P, which has been shown to potently stimulate GTPgS binding activity in S1P-transfected CHO cells (EC50 = 210 pM, 4.9 nM, 4.3 nM, and 1 nM for S1P1, S1P3, S1P4 and S1P5, respectively). |
Uses | A cell-permeable aminopropanediol immunosuppressive agent that displays lymphocyte sequestration properties. |
Definition | ChEBI: The hydrochloride salt of 2-amino-2-[2-(4-octylphenyl) ethyl]-1,3-propanediol (fingolimod). |
Company Profile Introduction
Henan CoreyChem Co., Ltd, based on the original Zhengzhou Cote Chemical Research Institute, be brave in absorbing highly educated talents & overseas returnees; actively responded to Zhengzhou City High-tech Zone Government’s Special Care Policy, reorganized and founded in National University of Science and Technology Park, which is a high-tech, stock enterprise of high-end chemical Custom synthesis;The park was created by the People's Government of Henan Province, and proved by Ministry of Education and the National Science & Technology, taking the construction mode of "many college a park, and common development", mainly depends on Zhengzhou University and Henan University’s scientific research and talent advantage to set up Universities, scientific research institute and enterprise scientific research achievements transformation platform, to make high-tech enterprises incubate, is the new high-tech talent gathering base, high and new technology industry enterprise radiation base, colleges and universities technological innovation base.
Henan Coreychem Co., Ltd, facing global High-tech pharmaceutical raw materials, high complex new type intermediates, fine chemicals custom synthesis, scale-up production and Rare chemicals trade. Corey have well-equipped machine, strong technical force and considerate marketing team service. We also have rich experience advantage in basic research, small scale process development, scale-up, industrial technology development & production and cost control.
Recommended supplier
-
VIP1年
- Synnat Pharma Pvt Ltd
- 162359-56-0 98%
- Inquiry
- 2024-03-21
-
VIP1年
- Mylan Laboratories Ltd
- 162359-56-0 Fingolimod hydrochloride 98%
- Inquiry
- 2024-03-06
-
VIP1年
- Shivalik Rasayan Ltd
- Fingolimod hydrochloride 162359-56-0 98%
- Inquiry
- 2024-02-22
-
VIP0年
- Glyra Health Care Pvt Ltd
- Fingolimod hydrochloride 99%
- Inquiry
- 2024-02-21
-
VIP1年
- Acute Research
- 162359-56-0 98%
- Inquiry
- 2024-01-29
-
VIP1年
- Ascott Pharma
- 162359-56-0 Fingolimod hydrochloride 98%
- Inquiry
- 2024-01-25
-
VIP1年
- Opulant Pharmaceuticals Pvt Ltd
- Fingolimod hydrochloride 98%
- Inquiry
- 2024-01-11
-
VIP1年
- Shilpa Medicare Limited (SML)
- Fingolimod hydrochloride 99%
- Inquiry
- 2024-01-11
-
VIP1年
- Honour Lab Limited
- 162359-56-0 98%
- Inquiry
- 2024-01-08
-
VIP1年
- Hetero Drugs Limited
- 162359-56-0 Fingolimod hydrochloride 98%
- Inquiry
- 2024-01-08
- Since:2014-12-17
- Address: No.967,15th Floor,Unit 7, Building 1, No.70 of DianChang Road, High-tech Development Zone, Zhengzho
INQUIRY